EFSA |
European Food Safety Authority |
BMI |
body mass index |
HbA1c
|
glycated hemoglobin |
FBG |
fasting blood glucose |
TC |
total cholesterol |
TG |
triglycerides |
H2O2
|
hydrogen peroxide |
SI |
serum insulin |
FSI |
fasting serum insulin |
ROS |
reactive oxygen species |
NF-κβ |
nuclear factor-κβ |
NADH |
nicotinamide adenine dinucleotide + hydrogen |
HOMA-IR |
homeostasis model assessment insulin resistance |
GLUT-4 |
glucose transporter type 4 |
GLUT-1 |
glucose transporter type 1 |
PPG60min
|
postprandial glucose level (60 min) |
PPG30min
|
postprandial glucose level (30 min) |
PPG120min |
postprandial glucose level (120 min) |
OGTT |
oral glucose tolerance test |
NOAEL |
not observed adverse effect level |
DPPH |
2,2-diphenyl-1-picrylhydrazyl |
ABTS |
2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) |
FRAP |
ferric reducing antioxidant power |
LDL |
low-density lipoprotein |
UCP-1 |
uncoupling protein 1 |
PPAR-α |
peroxisome proliferator-activated receptor alpha |
CRP |
C-reactive protein |
FDA |
Food and Drug Administration |